Literature DB >> 20963326

Sampling studies to estimate the HIV prevalence rate in female commercial sex workers.

Ana Roberta Pati Pascom1, Célia Landmann Szwarcwald, Aristides Barbosa Júnior.   

Abstract

INTRODUCTION: We investigated sampling methods being used to estimate the HIV prevalence rate among female commercial sex workers.
METHODS: The studies were classified according to the adequacy or not of the sample size to estimate HIV prevalence rate and according to the sampling method (probabilistic or convenience).
RESULTS: We identified 75 studies that estimated the HIV prevalence rate among female sex workers. Most of the studies employed convenience samples. The sample size was not adequate to estimate HIV prevalence rate in 35 studies. DISCUSSION: The use of convenience sample limits statistical inference for the whole group. It was observed that there was an increase in the number of published studies since 2005, as well as in the number of studies that used probabilistic samples. This represents a large advance in the monitoring of risk behavior practices and HIV prevalence rate in this group.

Mesh:

Year:  2010        PMID: 20963326

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  8 in total

1.  Consistently low prevalence of syphilis among female sex workers in Jinan, China: findings from two consecutive respondent driven sampling surveys.

Authors:  Meizhen Liao; Xijuan Nie; Rongjian Pan; Chuangxin Wang; Shiman Ruan; Changqing Zhang; Dianming Kang; Jihua Fu; Yuesheng Qian; Xiaorun Tao; Jinkou Zhao
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

Review 2.  Hard-to-reach populations of men who have sex with men and sex workers: a systematic review on sampling methods.

Authors:  Ana B Barros; Sonia F Dias; Maria Rosario O Martins
Journal:  Syst Rev       Date:  2015-10-30

3.  HIV risk practices by female sex workers according to workplace.

Authors:  Giseli Nogueira Damacena; Célia Landmann Szwarcwald; Paulo Roberto Borges de Souza Júnior
Journal:  Rev Saude Publica       Date:  2014-06       Impact factor: 2.106

4.  Factors associated with HIV infection among female sex workers in Brazil.

Authors:  Célia Landmann Szwarcwald; Giseli Nogueira Damacena; Paulo Roberto Borges de Souza-Júnior; Mark Drew Crosland Guimarães; Wanessa da Silva de Almeida; Arthur Pate de Souza Ferreira; Orlando da Costa Ferreira-Júnior; Inês Dourado
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

5.  Prevalence estimates of HIV, syphilis, hepatitis B and C among female sex workers (FSW) in Brazil, 2016.

Authors:  Orlando da Costa Ferreira-Júnior; Mark Drew Crosland Guimarães; Giseli Nogueira Damacena; Wanessa da Silva de Almeida; Paulo Roberto Borges de Souza-Júnior; Célia Landmann Szwarcwald
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

6.  Changes in attitudes, risky practices, and HIV and syphilis prevalence among female sex workers in Brazil from 2009 to 2016.

Authors:  Célia Landmann Szwarcwald; Wanessa da Silva de Almeida; Giseli Nogueira Damacena; Paulo Roberto Borges de Souza-Júnior; Orlando da Costa Ferreira-Júnior; Mark Drew Crosland Guimarães
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

7.  Effect of community active case-finding strategies for detection of tuberculosis in Cambodia: study protocol for a pragmatic cluster randomized controlled trial.

Authors:  Alvin Kuo Jing Teo; Kiesha Prem; Konstantin Evdokimov; Chetra Ork; Sothearith Eng; Sovannary Tuot; Monyrath Chry; Tan Eang Mao; Li Yang Hsu; Siyan Yi
Journal:  Trials       Date:  2020-02-24       Impact factor: 2.279

8.  Correlates of HIV self-testing among female sex workers in China: implications for expanding HIV screening.

Authors:  Cheng Wang; Ya-Jie Wang; Joseph D Tucker; Ming-Zhou Xiong; Hong-Yun Fu; M Kumi Smith; Wei-Ming Tang; Jason J Ong; He-Ping Zheng; Bin Yang
Journal:  Infect Dis Poverty       Date:  2020-10-22       Impact factor: 4.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.